Low-Level Laser Therapy: an Efficient Supplement to Treatments of Vulvar Lichen Sclerosus to Improve Quality of Life
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Objectives: The aim of this study was to investigate whether Low Level Laser therapy (LLLT) can improve the quality of life in women with Lichen Sclerosus (LS) and insufficient topical treatment. Methods: In a clinical trial study conducted between January 2016 and July 2018, the investigators included 100 women with LS with insufficient topical treatment. All participants received ten LLLT treatments (808 nm and 500 mW) over a period of 8 weeks. The first four treatments where planned as two treatments per week. The remaining six treatments where planned as once a week. The effect was monitored by a Danish health-related quality of life tool (HRQoL test).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable quality-of-life
Started Jan 2016
Typical duration for not_applicable quality-of-life
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedFirst Submitted
Initial submission to the registry
September 16, 2021
CompletedFirst Posted
Study publicly available on registry
September 29, 2021
CompletedOctober 6, 2021
September 1, 2021
2.5 years
September 16, 2021
September 28, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of life, scale
Danish health-related quality of life tool
up to 10 weeks
Study Arms (1)
Low Level Laser
EXPERIMENTALEasyLaser: Low Level Laser 808 nm and 500 mW. The first four treatments where planned as two treatments per week. The remaining six treatments where planned as once a week.
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosed with lichen sclerosus either clinically or by histopathological verification
- Age ≥ 18 years
- No significant relief in symptoms despite of topical treatment with potent steroids or calcineurin inhibitors
You may not qualify if:
- Age \< 18 years
- History of vulvar intraepithelial neoplasi
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kolding Sygehuslead
Study Officials
- STUDY CHAIR
Annemette Lykkebo, MD
Sygehus Lillebælt, Kolding.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2021
First Posted
September 29, 2021
Study Start
January 1, 2016
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
October 6, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
Not planned.